These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


668 related items for PubMed ID: 19642125

  • 21. Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.
    Fiel MI, Agarwal K, Stanca C, Elhajj N, Kontorinis N, Thung SN, Schiano TD.
    Liver Transpl; 2008 Jun; 14(6):861-71. PubMed ID: 18508382
    [Abstract] [Full Text] [Related]

  • 22. Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis.
    Berenguer M, Aguilera V, Prieto M, Ortiz C, Rodríguez M, Gentili F, Risalde B, Rubin A, Cañada R, Palau A, Rayón JM.
    Liver Transpl; 2009 Jul; 15(7):738-46. PubMed ID: 19562707
    [Abstract] [Full Text] [Related]

  • 23. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
    Kugelmas M, Osgood MJ, Trotter JF, Bak T, Wachs M, Forman L, Kam I, Everson GT.
    Liver Transpl; 2003 Nov; 9(11):1159-65. PubMed ID: 14586876
    [Abstract] [Full Text] [Related]

  • 24. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS, Russo MW, Borczuk AC, Brown M, Esposito SP, Lobritto SJ, Jacobson IM, Brown RS.
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [Abstract] [Full Text] [Related]

  • 25. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection : an observational multicenter study.
    Saliba F, Lakehal M, Pageaux GP, Roche B, Vanlemmens C, Duvoux C, Dumortier J, Salamé E, Calmus Y, Maugendre D, Diapason Study Group.
    Liver Transpl; 2007 Jan; 13(1):136-44. PubMed ID: 17192854
    [Abstract] [Full Text] [Related]

  • 26. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
    Burra P, Senzolo M, Masier A, Prestele H, Jones R, Samuel D, Villamil F.
    Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
    [Abstract] [Full Text] [Related]

  • 27. Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation.
    Ueda Y, Kaido T, Ito T, Ogawa K, Yoshizawa A, Fujimoto Y, Mori A, Miyagawa-Hayashino A, Haga H, Marusawa H, Chiba T, Uemoto S.
    Transplantation; 2014 Feb 15; 97(3):344-50. PubMed ID: 24157473
    [Abstract] [Full Text] [Related]

  • 28. Liver transplantation and hepatitis C.
    Willems M, Metselaar HJ, Tilanus HW, Schalm SW, de Man RA.
    Transpl Int; 2002 Mar 15; 15(2-3):61-72. PubMed ID: 11935162
    [Abstract] [Full Text] [Related]

  • 29. Hepatitis C after liver transplantation.
    Sheiner PA.
    Semin Liver Dis; 2000 Mar 15; 20(2):201-9. PubMed ID: 10946424
    [Abstract] [Full Text] [Related]

  • 30. [Combined antiviral treatment in a patient with recurrent chronic hepatitis C after liver transplantation].
    Csák T, Folhoffer A, Horváth A, Lengyel G, Kóbori L, Szalay F.
    Orv Hetil; 2004 Sep 26; 145(39):2003-6. PubMed ID: 15553912
    [Abstract] [Full Text] [Related]

  • 31. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C, Federico A, Masarone M, Torella R, Blanco Cdel V, Persico M.
    Am J Gastroenterol; 2008 Dec 26; 103(12):3159-66. PubMed ID: 18786125
    [Abstract] [Full Text] [Related]

  • 32. Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin.
    Vukotic R, Gramenzi A, Vitale G, Cursaro C, Serra C, Biselli M, Scuteri A, Andreone P, Bernardi M.
    Liver Int; 2008 Mar 26; 28(3):407-11. PubMed ID: 17900241
    [Abstract] [Full Text] [Related]

  • 33. Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
    Berenguer M, Aguilera V, Prieto M, San Juan F, Rayón JM, Benlloch S, Berenguer J.
    J Hepatol; 2006 Apr 26; 44(4):717-22. PubMed ID: 16487616
    [Abstract] [Full Text] [Related]

  • 34. Recurrent hepatitis C after liver transplantation.
    Sheiner P, Rochon C.
    Mt Sinai J Med; 2012 Apr 26; 79(2):190-8. PubMed ID: 22499490
    [Abstract] [Full Text] [Related]

  • 35. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 26; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 36. Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection.
    Jain A, Vekatramanan R, Yelochan B, Kashyap R, Marcos A, Fung J.
    Transplant Proc; 2005 Sep 26; 37(7):3190-6. PubMed ID: 16213346
    [Abstract] [Full Text] [Related]

  • 37. Late occurrence of pleural and peritoneal effusion due to Mycobacterium tuberculosis infection (TB) in a patient with posttransplantation recurrent HCV chronic hepatitis: safety of peginterferon and ribavirin treatment after recovery of TB:- a case report.
    Grasso A, De Leo P, Malfatti F, Toscanini F, Anselmo M, Menardo G.
    Transplant Proc; 2008 Jun 26; 40(5):1783-5. PubMed ID: 18589196
    [Abstract] [Full Text] [Related]

  • 38. [Clinical guidelines of diagnosis and treatment of hepatitis C].
    Rev Gastroenterol Mex; 2007 Jun 26; 72(2):177-91. PubMed ID: 17966381
    [No Abstract] [Full Text] [Related]

  • 39. The natural history of hepatitis C cirrhosis after liver transplantation.
    Firpi RJ, Clark V, Soldevila-Pico C, Morelli G, Cabrera R, Levy C, Machicao VI, Chaoru C, Nelson DR.
    Liver Transpl; 2009 Sep 26; 15(9):1063-71. PubMed ID: 19718647
    [Abstract] [Full Text] [Related]

  • 40. Long-term outcome of hepatitis C virus infections acquired after pediatric liver transplantation.
    Venturi C, Bueno J, Castells L, Quintero J, Casas I, Allende H, Martinez-Ibañez V, Charco R.
    Liver Transpl; 2011 Dec 26; 17(12):1474-80. PubMed ID: 21932378
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 34.